Skip to main content

Animations

MJFF Publications

891 - 900 of 6564 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Tracking cortical excitability dynamics with transcranial magnetic stimulation in focal epilepsy
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51535
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Resilience and Trauma among Patients with Parkinson’s Disease during the COVID-19 Pandemic
    Journal Name: Journal of Movement Disorders
    Publisher: The Korean Movement Disorder Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.14802/jmd.20126
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Leveraging Patient Preference Information in Medical Device Clinical Trial Design
    Journal Name: Therapeutic Innovation & Regulatory Science
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s43441-022-00450-9
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables
    Journal Name: Neurological Sciences
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s10072-022-06061-4
    Citation Count: 35
  • Summary Details
    OPEN
    Title: The silver linings of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00283-1
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Screening performances of an 8-item UPSIT Italian version in the diagnosis of Parkinson’s disease
    Journal Name: Neurological Sciences
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s10072-022-06457-2
    Citation Count: 8
  • Summary Details
    OPEN
    Title: The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England
    Journal Name: PharmacoEconomics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40273-022-01132-y
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Late Breaking Orals
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/jev2.12252
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Vascular risk profile and white matter hyperintensity volume among Mexican Americans and non‐Hispanic Whites: The HABLE study
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/dad2.12263
    Citation Count: 18
  • Summary Details
    OPEN
    Title: The National Institute on Aging Late‐Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.12514
    Citation Count: 18
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.